Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naive Relapsed Multiple Myeloma

Afrough, A; Atrash, S; Paul, B; Ouchveridze, E; Ahmed, N; Mahmoudjafari, Z; Bashir, A; Alkharabsheh, O; Hashmi, H; Abdallah, A

Afrough, A (通讯作者)，UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Hematol Malignancies & Cellular Therapy Program, Dallas, TX 75390 USA.;Afrough, A (通讯作者)，US Myeloma Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA.

CANCERS, 2023; 15 (19):

Abstract

Simple Summary We have been studying different combinations of medications to treat relapsed or refractory multiple myeloma. Among these combinations,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索